Public-registry site landscape for NCT05737940, a Pulmonary Hypertension (World Health Organization Group 2) study sponsored by AstraZeneca. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05737940 (registry record) |
| Sponsor | AstraZeneca |
| Condition(s) | Pulmonary Hypertension (World Health Organization Group 2); Heart Failure |
| Phase | PHASE2 |
| Listed sites | 60 |
| Site countries | United States, Austria, Canada, China, Czechia, Denmark, Germany, Italy, Japan, Netherlands, Poland, Spain |
Eichor generates a preliminary site-risk snapshot for NCT05737940 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →